BMO Capital initiated coverage of Legence (LGN) with an Outperform rating and $36 price target The firm sees a compelling risk/reward at current share levels. Legence is well positioned to benefit from the “significant” investment cycle in data centers, advanced manufacturing, and healthcare, the analyst tells investors in a research note. BMO sees potential acquisitions providing a further upside to estimates.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LGN:
- Legence initiated with a Buy at Goldman Sachs
- Hold Rating for Legence Corp.: Balancing High Growth Potential with Financial and Execution Risks
- Strategic Growth and Stability: Legence Corp.’s Buy Rating Driven by Data Center Demand and M&A Opportunities
- Legence Corp. Positioned for Significant Growth Amidst Energy Efficiency and Skilled Labor Trends
- Legence Corp. Class A: Positioned for Growth with Strategic Market Presence and Upside Potential